De novo Acute Myeloid Leukemia
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia Trial in Taipei
Enrolling by invitation
- Acute Myeloid Leukemia
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 9, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
Sep 22, 2023
Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Atovaquone
- +4 more
-
Baltimore, Maryland
- +1 more
Oct 7, 2022
Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Standard Intervention
- Investigational Intervention
- (no location specified)
Aug 8, 2023
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Active, not recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
-
Sewell, New Jersey
- +4 more
Dec 13, 2022
MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)
Recruiting
- Myelodysplastic Syndromes, de Novo
- +10 more
- Venetoclax
- +10 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 23, 2023
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)
Completed
- Novo Acute Myeloid Leukemia
-
Badalona, Barcelona, Spain
- +5 more
Jan 26, 2021
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)
Not yet recruiting
- Acute Myeloid Leukemia
- Cytarabine and Idarubicin
- CPX-315
-
Amiens, France
- +29 more
Apr 8, 2022
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
PET Tracer Based FDG Signal for Predicting Prognosis in Acute
Enrolling by invitation
- Acute Myeloid Leukemia
- No intervention
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Jinan University
Jun 22, 2023
Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56
Not yet recruiting
- Acute Myeloid Leukemia
- bone marrow aspirate and biopsy
- (no location specified)
Aug 20, 2022
Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)
Recruiting
- Refractory/Relapse Acute Myeloid Leukemia
-
Kunming, Yunnan, ChinaDepartment of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +23 more
- treosulfan
- +7 more
-
Denver, Colorado
- +2 more
Jun 17, 2021
Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker
Completed
- Acute Myeloid Leukemia
- +4 more
- Laboratory Biomarker Analysis
- Selinexor
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 12, 2021
Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte
Recruiting
- Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- "3+7"
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 29, 2023
Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou
Not yet recruiting
- Systemic Mastocytosis With AHNMD
- Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Aug 16, 2022
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute
Recruiting
- Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +9 more
- Cytarabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2021
Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 13, 2022
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023